ClinicalTrials.Veeva

Menu

The Early Origins of Cardiovascular Disease

D

Danone Institute International

Status

Unknown

Conditions

Cardiovascular Disease

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Small body size at birth, slow weight gain during infancy and increase in body mass index after 2 years are independent risk factors for cardiovascular disease and the metabolic syndrome. There is a large gap in our understanding of how early growth affects the cardiovascular system. Possible mechanisms include alterations in body composition, in cardiac structure, in vascular function, in renal function and epigenetic processes.

The Objective is to determine how size at birth and growth during infancy and childhood affect: body composition, cardiac structure and function, vascular and endothelial function, renal function, metabolic status and transcriptional and epigenetic characteristics.

Enrollment

200 estimated patients

Sex

All

Ages

18 to 25 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Male and female volunteers students aged between 18-25 years old
  • Having growth records

Exclusion criteria

  • If young women subject without contraception,or pregnant

Trial design

200 participants in 1 patient group

Exposed/ Not exposed

Trial contacts and locations

1

Loading...

Central trial contact

Umberto SIMEONI, MD,PhD; Olivier BLIN, MD,PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems